Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity

By Targońska-Stępniak Bożena  

Rheumatology International, Vol. 28, Iss. 6, 2008-04 ,pp. : 585-591

Springer Publishing Company

Access to resources Recommend Favorite

Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study

By Ateş Aşkin   Kinikli Gülay   Turgay Murat   Akay Gülay   Tokgöz Güner  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 538-545

Springer Publishing Company

Access to resources Recommend Favorite

IgA rheumatoid factor in primary Sjogren's syndrome

By Peen E.   Mellbye O. J.   Haga H-J.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 1, 2009-01 ,pp. : 46-49

Informa Healthcare

Access to resources Recommend Favorite

Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor

By Origuchi Tomoki  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 244-250

Springer Publishing Company

Access to resources Recommend Favorite

Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis

By Kasama Tsuyoshi   Isojima Sakiko   Umemura Masayu   Tsukamoto Hiroyuki   Tokunaga Takehiro   Furuya Hidekazu   Yanai Ryo   Takahashi Ryo   Nakamura Masanori   Inagaki Katsunori  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 429-433

Springer Publishing Company

Access to resources Recommend Favorite